Schonfeld Strategic Advisors’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-81,530
Closed -$1.61M 2167
2025
Q4
$1.61M Buy
81,530
+70,702
+653% +$1.27M 0.01% 948
2025
Q3
$189K Sell
10,828
-127,228
-92% -$1.89M ﹤0.01% 1953
2025
Q2
$1.93M Buy
138,056
+74,520
+117% +$1.2M 0.01% 1009
2025
Q1
$1.18M Buy
+63,536
New +$947K 0.01% 1214
2023
Q3
Sell
-11,480
Closed -$66K 1740
2023
Q2
$66K Buy
+11,480
New +$74.2K ﹤0.01% 1786
2023
Q1
Sell
-234,625
Closed -$2.76M 2062
2022
Q4
$2.76M Buy
234,625
+120,366
+105% +$1.46M 0.02% 695
2022
Q3
$1.35M Buy
+114,259
New +$1.67M 0.01% 1086
2022
Q2
Sell
-30,000
Closed -$337K 2492
2022
Q1
$337K Buy
+30,000
New +$270K ﹤0.01% 1618
2021
Q4
Sell
-25,000
Closed -$400K 2105
2021
Q3
$400K Buy
+25,000
New +$483K ﹤0.01% 1376
2021
Q2
Sell
-30,300
Closed -$664K 1908
2021
Q1
$664K Buy
+30,300
New +$592K 0.01% 1046

Other funds holding ALHC

Schonfeld Strategic Advisors's ALHC Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 81,530 shares — an estimated $1.61M sold.

Schonfeld Strategic Advisors first reported a position in ALHC in Q1 2021 and held it in 10 quarters. The position peaked at $2.76M in Q4 2022. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 81,530 Alignment Healthcare shares in Q1 2026, an estimated $1.61M.
  • Schonfeld Strategic Advisors first reported a position in Alignment Healthcare in Q1 2021 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Alignment Healthcare position peaked at $2.76M in Q4 2022.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.